about
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trialPaclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerCarboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activitiesProteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.The ClC-3 chloride channel associated with microtubules is a target of paclitaxel in its induced-apoptosis.Microtubule-Associated Protein Tau, α-Tubulin and βIII-Tubulin Expression in Breast Cancer.Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.Precision treatment for cancer: role of prognostic and predictive markers.Targeting mitotic pathways for endocrine-related cancer therapeutics.Docetaxel modulates the delayed rectifier potassium current (IK) and ATP-sensitive potassium current (IKATP) in human breast cancer cells.Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells.Collapsin response mediator protein 2 is involved in regulating breast cancer progression.FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy.BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer.Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption
P2860
Q28534786-5F5125ED-8077-4D64-AF41-9DDC23E5E503Q33586121-7FA80EF3-6F46-4FFB-A461-C86790D5FF49Q34005719-817079CC-E38B-4A71-B548-73F48D253F85Q34525286-5FDE35E9-700D-4094-AFC9-C67C381BED1BQ35057121-EBD13DF9-4237-4C7F-A5CA-D1A0A6361355Q35139059-80B8392E-A810-4BB9-BDB8-82766DD5CC4EQ37165362-49A150B2-97B4-4BA9-B657-67FF07E1B31AQ37459115-C560FAE3-3871-44FA-99AF-A1124F4EEA25Q38060185-95F3A5C5-2841-4311-AC72-7881D50E839AQ38179024-5C7C0503-7530-43A3-B3D0-703C1EA92D80Q38671036-E4EFE08D-5DAF-44FA-B4E6-4B69BAE51925Q38938154-C8653773-014A-464A-B7C1-FCD44339654AQ39191770-2AA0FCEC-8B86-4584-AA1C-A083B79BA71FQ40990185-7A171E6D-3873-4D03-8279-C14F6B061AACQ43592584-F8FAAA12-A0C4-406E-A874-1A1E5AD96BF2Q45212093-10226C99-FA3D-413A-8CA7-8E04EB374B1AQ46881099-E6527A0F-0608-4E42-ACDB-DE0A63CFE448Q48371625-E5AD2E53-EE07-4659-9C57-13EEE4C0E709Q49387560-25CB965B-4E35-43AE-9D15-CDCD0494A132Q52602328-B887DC17-70A5-4615-B1DB-31ACF800C95DQ53600525-745CAD76-4912-48AF-B34E-8F09BEB469B7Q59137604-1EBB8A43-3A36-4907-87DC-93275D718AF0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of Tau protein in resistance to paclitaxel.
@en
The role of Tau protein in resistance to paclitaxel.
@nl
type
label
The role of Tau protein in resistance to paclitaxel.
@en
The role of Tau protein in resistance to paclitaxel.
@nl
prefLabel
The role of Tau protein in resistance to paclitaxel.
@en
The role of Tau protein in resistance to paclitaxel.
@nl
P2093
P2860
P921
P1476
The role of Tau protein in resistance to paclitaxel.
@en
P2093
Bartłomiej Grala
Cezary Szczylik
Lubomir Bodnar
Marta Smoter
Rafał Stec
Renata Duchnowska
P2860
P2888
P304
P356
10.1007/S00280-011-1696-7
P577
2011-06-29T00:00:00Z
2011-09-01T00:00:00Z